What is Trileptal (oxcarbazepine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

What is Trileptal (Oxcarbazepine)?

Trileptal is an antiepileptic drug (AED) containing oxcarbazepine, approved for treating partial-onset seizures (also called focal seizures) in adults and children. 1

Licensed Indications

Trileptal (oxcarbazepine) is FDA-approved for:

  • Epilepsy - partial seizures with or without secondary generalized tonic-clonic seizures in adults and children aged 6 years and older 2
  • Can be used as monotherapy (alone) or adjunctive therapy (with other seizure medications) 1
  • In the US, approved as monotherapy in adults and as adjunctive therapy in children ≥4 years of age 1

How It Works

Oxcarbazepine works primarily by blocking voltage-sensitive sodium channels in the brain, which stabilizes overexcited nerve cell membranes and prevents seizure spread. 1 The drug also modulates calcium channels and increases potassium conductance, contributing to its anticonvulsant effects 1.

Key Pharmacological Features

Metabolism

  • Oxcarbazepine is rapidly converted to its active metabolite MHD (10-monohydroxy derivative), which is responsible for most of the antiepileptic activity 1, 3
  • The parent drug has a half-life of about 2 hours, while MHD has a half-life of about 9 hours 1
  • Unlike carbamazepine, oxcarbazepine undergoes reductive metabolism rather than oxidation by cytochrome P-450 enzymes, resulting in fewer drug interactions 3, 4

Available Formulations

  • Film-coated tablets: 150 mg, 300 mg, and 600 mg 1
  • Oral suspension: 300 mg/5 mL (60 mg/mL) 1

Critical Safety Considerations

Serious Risks Requiring Immediate Attention

1. Severe Cutaneous Adverse Drug Reactions (SCARs)

  • HLA-B*15:02 carriers have markedly increased risk of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) 2, 5
  • HLA-A*31:01 carriers have increased risk of drug reaction with eosinophilia and systemic symptoms (DRESS) and SJS/TEN 2, 5
  • Patients allergic to carbamazepine are often allergic to oxcarbazepine - avoid if carbamazepine allergy exists 1
  • The 2026 UK pharmacogenomics guideline recommends avoiding oxcarbazepine in HLA-B*15:02-positive patients and considering avoidance in HLA-A*31:01-positive patients 2

2. Hyponatremia (Low Sodium)

  • Can cause nausea, confusion, tiredness, more frequent seizures, and headache 1
  • Requires monitoring, especially in elderly patients 1

3. Multi-organ Hypersensitivity Reactions

  • Can affect liver, blood cells, and other organs 1
  • Watch for: fever, swollen glands, sore throat, unusual bruising/bleeding, severe fatigue, yellowing of skin/eyes 1

4. Suicidal Thoughts

  • Like all AEDs, carries risk of suicidal ideation (approximately 1 in 500 patients) 1

Common Side Effects

The most frequent adverse effects include 1:

  • Dizziness
  • Somnolence (sleepiness)
  • Diplopia (double vision)
  • Fatigue
  • Nausea and vomiting
  • Ataxia (coordination problems)
  • Headache

Drug Interactions

Oxcarbazepine has fewer drug interactions than carbamazepine but still requires attention: 1, 4

  • Decreases effectiveness of oral contraceptives - alternative contraception methods should be used 1, 4
  • Can increase phenytoin levels by 40% at doses above 1,200 mg 2
  • Strong enzyme inducers (carbamazepine, phenobarbital, phenytoin) can reduce MHD levels by 30-40% 4
  • Minimal effect on valproic acid and lamotrigine (unlike carbamazepine) 3

Dosing Considerations

  • Take twice daily, with or without food 1
  • Dose reduction of at least 50% required in patients with moderate to severe renal impairment (creatinine clearance <30 mL/min) 1
  • Children may require higher weight-adjusted doses due to faster renal clearance 1, 4
  • Never stop abruptly - can cause status epilepticus (continuous seizures) 1

Advantages Over Carbamazepine

Oxcarbazepine offers several clinical advantages over its predecessor carbamazepine: 3, 6

  • Better tolerability with fewer side effects
  • No autoinduction (more predictable dosing)
  • Linear pharmacokinetics
  • Fewer drug-drug interactions
  • Lower risk of serious blood disorders (no reported agranulocytosis or aplastic anemia cases)
  • Can be combined more effectively with other AEDs like valproate

Special Populations

  • Pregnancy: Unknown if harmful to fetus; pregnancy registry available (1-888-233-2334) 1
  • Breastfeeding: Passes into breast milk - discuss with healthcare provider 1
  • Elderly: Higher drug exposure due to reduced renal clearance; requires sodium monitoring 1
  • Children: Approved for ages 6+ (Europe) or 4+ (US for monotherapy); faster metabolism may require dose adjustments 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.